Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response to Metformin and Pioglitazone in Ataxia-Telangiectasia
NCT02733679Phase 4Completed
- Sponsor
- NHS Tayside
- Start
- Sep 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liquid metformin (Aspargo Labs), pioglitazone in ataxia-telangiectasia (AT), sponsored by NHS Tayside. Started Sep 2016; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)pioglitazone
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on NCT02733679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733679.